Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[beta-amyloidogenesis]

Y Ihara1

  • 1Department of Neuropathology, Faculty of Medicine University of Tokyo.

Rinsho Shinkeigaku = Clinical Neurology
|May 13, 1998
PubMed
Summary
This summary is machine-generated.

Amyloid beta-protein 42 (A beta 42) accumulation in the brain increases significantly after age 50, with higher levels linked to Alzheimer's disease. Amyloid beta-protein 40 (A beta 40) also increases in Alzheimer's, potentially accelerating disease development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Omalizumab reduces allergic rhinitis symptoms due to Japanese cedar pollen by improving eosinophilic inflammation.

Rhinology·2024
Same author

Nuclear magnetic resonance measurements in dynamically controlled field pulse.

The Review of scientific instruments·2021
Same author

Gastrointestinal: A case of zonisamide-induced esophageal and small intestinal injury.

Journal of gastroenterology and hepatology·2019
Same author

Transition of Spleen Volume Long After Pediatric Living Donor Liver Transplantation for Biliary Atresia.

Transplantation proceedings·2018
Same author

Endotoxin Metabolism Reflects Hepatic Functional Reserve in End-Stage Liver Disease.

Transplantation proceedings·2018
Same author

Antibody Drug Treatment for Steroid-Resistant Rejection After Pediatric Living Donor Liver Transplantation: A Single-Center Experience.

Transplantation proceedings·2018

Area of Science:

  • Neuroscience
  • Neuropathology
  • Biochemistry

Context:

  • Amyloid beta-protein (A beta) accumulation in the brain is a hallmark of aging and Alzheimer's disease (AD).
  • Understanding the temporal and quantitative aspects of A beta accumulation in different brain regions is crucial for elucidating AD pathogenesis.

Purpose:

  • To investigate the age-dependent accumulation of A beta 42 and A beta 40 in the human cortex.
  • To compare A beta accumulation patterns between normal aging and Alzheimer's disease brains.
  • To identify potential thresholds of A beta 42 for senile plaque formation.

Summary:

  • A beta 42 levels showed a steep increase between ages 50 and 70 in the occipitotemporal cortex (T4) and hippocampus CA1, with consistently higher levels in T4.
  • A critical A beta 42 level was identified below which senile plaques were not detected.

Related Experiment Videos

  • Alzheimer's disease brains exhibited significantly higher A beta 42 levels and greater N-terminal modifications compared to controls. A beta 40 accumulated with aging and was elevated in most AD brains, suggesting a role in disease acceleration.

    • Impact:

    • This study provides critical insights into the differential accumulation patterns of A beta 42 and A beta 40 during aging and in Alzheimer's disease.
    • Findings suggest that early A beta 42 accumulation may predispose individuals to late-onset AD, while elevated A beta 40 might accelerate disease progression.